Do not take PRISTIQ if you are allergic to desvenlafaxine, venlafaxine, or any of the ingredients in PRISTIQ. Do not take PRISTIQ if you currently take, or have taken within the last 14 days, any medicine known as an MAOI (including intravenous methylene blue or the antibiotic linezolid).
PRISTIQ is a prescription medication that’s FDA approved to treat depression in adults. PRISTIQ is an effective treatment for depression in adults. It’s proven to relieve the emotional and physical symptoms of depression as measured by the HAMD-17, a commonly used symptom rating scale.
In clinical studies, PRISTIQ 50 mg also helped improve patients' ability to function according to a scale* used to measure how depression disrupts works, social life/leisure activities, and family life/home responsibilities.
Everybody responds differently to treatment, so it’s important to give PRISTIQ time to work. It can take several weeks to feel the full benefits of a prescription antidepressant although some people may start to feel better sooner. Talk to your doctor about any concerns you may have.
*Sheehan Disability Scale (a validated measure of functional impairment) total score for PRISTIQ vs. placebo.
You may experience side effects while taking PRISTIQ. In clinical studies, the most common side effect with PRISTIQ 50 mg was nausea.
Other side effects included dizziness, sweating, constipation, and decreased appetite.
These are not all the possible side effects of PRISTIQ 50 mg. For a complete list of side effects, please see Section 6 of the full Prescribing Information.
If you’re concerned about side effects, talk to your doctor.
Most people start with a once-daily 50-mg dose of PRISTIQ (taken with or without food). Your doctor may keep you on your starting dose throughout your treatment. Talk to your doctor about any health conditions you may have, as your dose might be affected.
PRISTIQ should be taken at the same time each day and always swallowed whole, since the tablets are time released.
You should always take PRISTIQ exactly as instructed by your health care professional. Be sure to talk to your doctor about any health conditions you may have, as your dose might be affected.
Do not take PRISTIQ if you currently take, or have taken within the last 14 days, any medicine known as an MAOI (including intravenous methylene blue or the antibiotic linezolid). Allow 7 days after stopping PRISTIQ before starting an MAOI. Taking an MAOI with PRISTIQ can cause serious or even life-threatening side effects.
Before taking PRISTIQ, tell your healthcare professional about all prescription and over-the-counter medications and supplements you take or plan to take including: those to treat migraines or psychiatric disorders (including other antidepressants) to avoid serotonin syndrome, a potentially life-threatening condition; aspirin, NSAID pain relievers, or blood thinners because they may increase the risk of bleeding.
Do not take PRISTIQ with other medicines containing venlafaxine or desvenlafaxine.
Side effects may occur when stopping PRISTIQ (discontinuation symptoms), especially when therapy is stopped suddenly. Your health care provider may want to decrease your dose slowly to help avoid side effects. Some of these side effects may include:
Stopping an antidepressant medicine suddenly can cause other symptoms. Side effects may occur if PRISTIQ therapy is stopped suddenly. Your health care provider may want to decrease your dose slowly to help avoid these side effects. These side effects may include dizziness, nausea, headache, irritability, problems sleeping, anxiety, abnormal dreams, tiredness, sweating, and diarrhea.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.
The product information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries.
|Important Safety Information | Medication Guide for Patients | Prescribing Information ||